PARSIPPANY, N.J.--(BUSINESS WIRE)--Ferring Pharmaceuticals today announced the first patient in the United States with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder ...

WASHINGTON -- The gene therapy nadofaragene firadenovec (Adstiladrin) continued to demonstrate clinical activity in patients with high-risk bladder cancer, researchers reported. The long-term ...

Bladder cancer can be treated with several types of drugs. Gene therapy is now part of the mix. The FDA has approved a Ferring Pharmaceuticals gene therapy as a treatment for patients whose cancer is ...

The U.S. Food and Drug Administration has approved Adstiladrin, which is being billed as the first gene therapy treating high-risk, non-muscle-invasive bladder cancer. Adstiladrin is a non-replicating ...

Patients with a high-risk bladder cancer now have a new option to treat it. "This approval provides health care professionals with an innovative treatment option for patients with high-risk NMIBC that ...

Subscribe to The St. Louis American‘s free weekly newsletter for critical stories, community voices, and insights that matter. Sign up (StatePoint) When you think of a bladder cancer patient, you may ...

RICHMOND, Va. -- The Doctor Is In and you have questions. Living with bladder issues can impact your sleep, emotional well-being, and overall quality of life. Dr. Linda Burkett is a Urogynecologist ...

There’s a lot to juggle and process after receiving a metastatic bladder cancer diagnosis — follow-up tests, medical appointments, treatment regimens. All of it can feel overwhelming at times, adding ...

WASHINGTON -- Treatment with cretostimogene grenadenorepvec, an investigational intravesically delivered oncolytic immunotherapy, achieved high response rates in patients with high-risk ...

DEAR DR. ROACH: In two weeks, I am supposed to get Botox injections in my bladder for an overactive bladder (OAB) and my frequent need to urinate at nighttime. Are these injections safe? Are there any ...